A disparate subset of double-negative T cells contributes to the outcome of murine fulminant viral hepatitis via effector molecule fibrinogen-like protein 2

[1]  H. Ross,et al.  The regulatory T cell effector molecule fibrinogen‐like protein 2 is necessary for the development of rapamycin‐induced tolerance to fully MHC‐mismatched murine cardiac allografts , 2015, Immunology.

[2]  H. Zhou,et al.  Soluble FGL2, a novel effector molecule of activated hepatic stellate cells, regulates T-cell function in cirrhotic patients with hepatocellular carcinoma , 2014, Hepatology International.

[3]  P. Jia,et al.  MHC Class II Restricted Innate-Like Double Negative T Cells Contribute to Optimal Primary and Secondary Immunity to Leishmania major , 2014, PLoS pathogens.

[4]  Gui‐qing Li,et al.  C5a/C5aR pathway is essential for the pathogenesis of murine viral fulminant hepatitis by way of potentiating Fgl2/fibroleukin expression , 2014, Hepatology.

[5]  A. Jevnikar,et al.  Spi6 Protects Alloreactive CD4+ But Not CD8+ Memory T Cell From Granzyme B Attack by Double‐Negative T Regulatory Cell , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[6]  Li Zhang,et al.  Pretransplant Infusion of Donor B Cells Enhances Donor-Specific Skin Allograft Survival , 2013, PloS one.

[7]  T. Mak,et al.  Regulation of antigen‐expressing dendritic cells by double negative regulatory T cells , 2011, European journal of immunology.

[8]  K. Wong,et al.  The novel immunoregulatory molecule FGL2: a potential biomarker for severity of chronic hepatitis C virus infection. , 2010, Journal of hepatology.

[9]  J. Frelinger,et al.  Lung CD4−CD8− Double-Negative T Cells Are Prominent Producers of IL-17A and IFN-γ during Primary Respiratory Murine Infection with Francisella tularensis Live Vaccine Strain , 2010, The Journal of Immunology.

[10]  Q. Ning,et al.  Increased Killing of Liver NK Cells by Fas/Fas Ligand and NKG2D/NKG2D Ligand Contributes to Hepatocyte Necrosis in Virus-Induced Liver Failure , 2009, The Journal of Immunology.

[11]  Asha B. Pillai,et al.  Host natural killer T cells induce an interleukin-4-dependent expansion of donor CD4+CD25+Foxp3+ T regulatory cells that protects against graft-versus-host disease. , 2009, Blood.

[12]  F. Powrie,et al.  Regulatory lymphocytes and intestinal inflammation. , 2009, Annual review of immunology.

[13]  K. Wong,et al.  The novel CD4+CD25+ regulatory T cell effector molecule fibrinogen‐like protein 2 contributes to the outcome of murine fulminant viral hepatitis , 2009, Hepatology.

[14]  Xuetao Cao,et al.  CD69+CD4+CD25− T Cells, a New Subset of Regulatory T Cells, Suppress T Cell Proliferation through Membrane-Bound TGF-β11 , 2009, The Journal of Immunology.

[15]  M. Oukka,et al.  Expanded Double Negative T Cells in Patients with Systemic Lupus Erythematosus Produce IL-17 and Infiltrate the Kidneys1 , 2008, The Journal of Immunology.

[16]  Q. Ning,et al.  Fibrinogen-like protein 2/fibroleukin prothrombinase contributes to tumor hypercoagulability via IL-2 and IFN-gamma. , 2008, World journal of gastroenterology.

[17]  L. Lanier,et al.  Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus , 2007, Proceedings of the National Academy of Sciences.

[18]  Y. Shiratori,et al.  Systemic inflammatory response syndrome strongly affects the prognosis of patients with fulminant hepatitis B , 2007, Journal of Gastroenterology.

[19]  Wei Yang,et al.  New differentiation pathway for double-negative regulatory T cells that regulates the magnitude of immune responses. , 2007, Blood.

[20]  R. Oliveira,et al.  Disparate Immunoregulatory Potentials for Double-Negative (CD4− CD8−) αβ and γδ T Cells from Human Patients with Cutaneous Leishmaniasis , 2006, Infection and Immunity.

[21]  Q. Ning,et al.  Novel mfgl2 antisense plasmid inhibits murine fgl2 expression and ameliorates murine hepatitis virus type 3-induced fulminant hepatitis in BALB/cJ mice. , 2006, Human gene therapy.

[22]  Q. Ning,et al.  Cytokine-Induced Hepatic Apoptosis Is Dependent on FGL2/Fibroleukin: The Role of Sp1/Sp3 and STAT1/PU.1 Composite cis Elements , 2006, The Journal of Immunology.

[23]  Chee-Kin Hui,et al.  Immune system and hepatitis B virus infection. , 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[24]  S. Sakaguchi.  Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self , 2005, Nature Immunology.

[25]  E. Kuipers,et al.  Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection , 2005, Hepatology.

[26]  E. Keeffe,et al.  T cell immunity in hepatitis B and hepatitis C virus infection: implications for autoimmunity. , 2005, Autoimmunity reviews.

[27]  A. Hamad,et al.  B220+ Double-Negative T Cells Suppress Polyclonal T Cell Activation by a Fas-Independent Mechanism That Involves Inhibition of IL-2 Production , 2003, The Journal of Immunology.

[28]  Q. Ning,et al.  The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis. , 2003, The Journal of clinical investigation.

[29]  N. Lycke,et al.  A Unique Population of Extrathymically Derived αβTCR+CD4−CD8− T Cells with Regulatory Functions Dominates the Mouse Female Genital Tract 1 , 2003, The Journal of Immunology.

[30]  Li Zhang,et al.  The Immune Regulatory Function of Lymphoproliferative Double Negative T Cells In Vitro and In Vivo , 2002, The Journal of experimental medicine.

[31]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[32]  J. Priatel,et al.  TCR/Self-Antigen Interactions Drive Double-Negative T Cell Peripheral Expansion and Differentiation into Suppressor Cells1 , 2001, The Journal of Immunology.

[33]  C. W. Chan,et al.  Fulminant viral hepatitis: molecular and cellular basis, and clinical implications , 2001, Expert Reviews in Molecular Medicine.

[34]  B. Diamond,et al.  Human Double-Negative T Cells in Systemic Lupus Erythematosus Provide Help for IgG and Are Restricted by CD1c1 , 2000, The Journal of Immunology.

[35]  Li Zhang,et al.  Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression , 2000, Nature Medicine.

[36]  P. Marsden,et al.  Molecular and Functional Analysis of the Human Prothrombinase Gene (HFGL2) and Its Role in Viral Hepatitis , 2000, The American Journal of Pathology.

[37]  C. Seeger,et al.  Hepatitis B Virus Biology , 2000, Microbiology and Molecular Biology Reviews.

[38]  M. Lai,et al.  The Nucleocapsid Protein of Murine Hepatitis Virus Type 3 Induces Transcription of the Novel fgl2 Prothrombinase Gene* , 1999, The Journal of Biological Chemistry.

[39]  Ming Liu,et al.  Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response. , 1998, Journal of immunology.

[40]  J. Leibowitz,et al.  Association of mouse fibrinogen-like protein with murine hepatitis virus-induced prothrombinase activity , 1995, Journal of virology.

[41]  F. Chisari,et al.  Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis , 1993, The Journal of experimental medicine.

[42]  G. Gros,et al.  Switch of CD8 T cells to noncytolytic CD8-CD4- cells that make TH2 cytokines and help B cells. , 1993, Science.

[43]  S. Chung,et al.  Monoclonal antibody analysis of a unique macrophage procoagulant activity induced by murine hepatitis virus strain 3 infection. , 1991, The Journal of biological chemistry.

[44]  R. Oliveira,et al.  Disparate immunoregulatory potentials for double-negative (CD4- CD8-) alpha beta and gamma delta T cells from human patients with cutaneous leishmaniasis. , 2006, Infection and immunity.

[45]  G. Pape,et al.  Immunology of hepatitis B infection. , 2002, The Lancet. Infectious diseases.

[46]  A. Hayday.  [gamma][delta] cells: a right time and a right place for a conserved third way of protection. , 2000, Annual review of immunology.

[47]  Q. Ning,et al.  Expression of the fgl2 and its protein product (prothrombinase) in tissues during murine hepatitis virus strain-3 (MHV-3) infection. , 1998, Advances in experimental medicine and biology.

[48]  S. Park,et al.  Mouse CD1-specific NK1 T cells: development, specificity, and function. , 1997, Annual review of immunology.

[49]  A. Bendelac.  Mouse NK1+ T cells. , 1995, Current opinion in immunology.